Skip to main
  1. Stocks
  2. Inspire Medical Systems Inc
  3. Forecast
INSP

INSP Stock Forecast & Price Target

INSP Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 19%
Hold 56%
Sell 6%
Strong Sell 6%

Bulls say

Inspire Medical Systems is attractive because 3Q revenue of $206.7M and adj. EPS of $0.14 beat expectations, with U.S. revenue of about $197.5M offsetting softer OUS sales and gross margin reaching 86.0% on a favorable Inspire V mix. The company also narrowed FY26 revenue guidance to $850M-$860M while lifting the midpoint of adj. EPS guidance to $1.20-$1.40, suggesting management sees the current coding and reimbursement headwinds easing rather than worsening. Investor confidence is further supported by new CPT codes effective January 1, 2028, which should reduce procedure-coding confusion, improve visibility into the 2027 trajectory, and help support continued adoption in the still-nascent U.S. surgical OSA market.

Bears say

Inspire Medical Systems is facing a negative outlook because its recent modest 3Q revenue and EPS beat was driven mainly by about $5M of U.S. upside, while softer international performance and a guidance cut earlier in the year reinforced concerns that growth is slowing. Management’s expectation for a return to growth in 2027 does not offset near-term pressure from coding and reimbursement frictions, which are limiting profitability and leaving less conviction that the company can consistently exceed guidance. Even with a potential new Category I code by Jan 1 2028 and longer-term support from Inspire 5, structural headwinds such as capacity constraints, GLP1-driven TAM pressure, competition, and launch delays could keep growth constrained.

INSP has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 19% recommend Buy, 56% suggest Holding, 6% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.

INSP Analyst Forecast & Price Prediction

Get the latest INSP stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in INSP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inspire Medical Systems Inc (INSP) Forecast

Analysts have given INSP a Hold based on their latest research and market trends.

According to 16 analysts, INSP has a Hold consensus rating as of Nov 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $81, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $81, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inspire Medical Systems Inc (INSP)


INSP Analyst Forecast & Price Prediction

Get the latest INSP stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in INSP

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover INSP stock data and trends